Cancer that originates or develops in the lining of the stomach is called gastric or stomach cancer. It usually grows slowly over several years before resulting in symptoms. This results in cancer getting diagnosed at a later stage, which usually affects the prognosis. Gastric cancer can develop at any part of the stomach, but mostly, they form in the main part (stomach body) or the esophagus (the part that carries food to the stomach when you swallow.
Adenocarcinoma - Almost 95 % of people develop adenocarcinoma, which starts in the tissues that line the stomach. The three types of adenocarcinoma are:
The location of stomach cancer determines the treatment plan. Surgery is recommended, along with other treatment options before or after the surgery. MSK's gastric cancer experts offer complete cancer care for people with all types of stomach cancer. These experts see more patients with this type of cancer than any other cancer center in the US. The advanced and accurate staging of gastric cancer and improved surgical techniques, diagnosis, treatment, and prognosis have significantly improved. Depending on the test results, the doctor might suggest surgery, chemotherapy, radiotherapy, or a combination of therapies. Patients can also benefit from the thousands of clinical trials ongoing at MSK that explore new therapies.
Instead of the stomach body, esophageal cancer develops inside the 10-inch hollow tube that carries food to the stomach called the esophagus. When the cells that line this tube start growing out of control, a tumor can form. The cells in the innermost layer mostly undergo a cancerous transformation, which can grow and multiply uncontrollably and invade the lymph nodes and other organs. Esophageal cancer is rare, but more people are developing the adenocarcinoma type in the past few years.
MSK's esophageal cancer experts use various methods, such as physical examination, imaging tests (CT scan, PET scan), and endoscopy, to diagnose and stage esophageal cancer. The type of surgery will be decided based on the cancer type and stage and the patient’s general health. Depending on the results, the doctor might suggest surgery, chemotherapy, radiotherapy, or a combination of therapies. Patients can also benefit from the thousands of clinical trials ongoing at MSK that explore new therapies. Patients with conditions that increase esophageal cancer risk, such as Barrett’s esophagus, get screened and monitored regularly for cancerous changes by MSK experts. Endoscopic or minimally invasive therapy is also available for precancerous and early-stage cancerous conditions.
Email:
mskccindia@icliniq.comPhone Number:
+91 82 700 70000